Advertisement
Screener

NYSE:OSTX | Share-based Payment Arrangement, Noncash Expense | OS Therapies Inc

0.2 / 5 stars · 4/120 Roast Me

OS Therapies Inc Share-based Payment Arrangement, Noncash Expense

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-14

  • OS Therapies Inc share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.33M, a 47.05% increase year-over-year.
  • OS Therapies Inc share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.44M, a 52.49% increase year-over-year.
  • OS Therapies Inc share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.60M.
  • OS Therapies Inc share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $814.93K.
  • OS Therapies Inc share-based payment arrangement, noncash expense for fiscal 2025 was $4.27M, a 1490.00% increase from fiscal 2024.
  • OS Therapies Inc share-based payment arrangement, noncash expense for fiscal 2024 was $268.30K.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$1.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$2.77M
10-Q · filed 2026-08-14
$4.37M
derived: sum of 3 quarters · filed 2026-08-14
$5.19M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$1.44M
10-Q · filed 2026-05-18
$3.04M
derived: sum of 2 quarters · filed 2026-05-18
$3.85M
derived: sum of 3 quarters · filed 2026-05-18
$4.76M
derived: sum of 4 quarters · filed 2026-05-18
2025-12-31$1.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$2.42M
derived: sum of 2 quarters · filed 2026-03-31
$3.32M
derived: sum of 3 quarters · filed 2026-03-31
$4.27M
10-K · filed 2026-03-31
2025-09-30$814.93K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$1.72M
derived: sum of 2 quarters · filed 2025-11-14
$2.66M
10-Q · filed 2025-11-14
2025-06-30$905.18K
10-Q · filed 2025-08-18
$1.85M
10-Q · filed 2026-08-14
2025-03-31$941.28K
10-Q · filed 2026-05-18
2024-12-31$268.30K
10-K · filed 2026-03-31